BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE and DRUG INEFFECTIVE FOR UNAPPROVED INDICATION

1 reports of this reaction

50.0% of all BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE reports

#2 most reported adverse reaction

Overview

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION is the #2 most commonly reported adverse reaction for BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, manufactured by Fresenius Kabi USA, LLC. There are 1 FDA adverse event reports linking BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE to DRUG INEFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 50.0% of all 2 adverse event reports for this drug.

Patients taking BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE who experience drug ineffective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION1 of 2 reports

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION is a frequently reported adverse event for BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, accounting for a significant proportion of all reports.

Other Side Effects of BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE

In addition to drug ineffective for unapproved indication, the following adverse reactions have been reported for BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE:

Other Drugs Associated with DRUG INEFFECTIVE FOR UNAPPROVED INDICATION

The following drugs have also been linked to drug ineffective for unapproved indication in FDA adverse event reports:

ACETAMINOPHEN AND IBUPROFENACETAMINOPHEN, ASPIRIN, CAFFEINEACETAMINOPHEN, IBUPROFENACETAZOLAMIDEASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATEBIVALIRUDINBUTENAFINE HYDROCHLORIDECRISABOROLEISOPROTERENOL HYDROCHLORIDELIDOCAINELIDOCAINE 4%NYSTATIN AND TRIAMCINOLONE ACETONIDEOSELTAMIVIRPHENOBARBITAL SODIUMREMDESIVIR

Frequently Asked Questions

Does BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE cause DRUG INEFFECTIVE FOR UNAPPROVED INDICATION?

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 1 FDA reports for BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE FOR UNAPPROVED INDICATION with BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE?

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 50.0% of all adverse event reports for BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, making it one of the most commonly reported side effect.

What should I do if I experience DRUG INEFFECTIVE FOR UNAPPROVED INDICATION while taking BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE?

If you experience drug ineffective for unapproved indication while taking BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

BENZALKONIUM CHLORIDE, LIDOCAINE HYDROCHLORIDE Full ProfileAll Drugs Causing DRUG INEFFECTIVE FOR UNAPPROVED INDICATIONFresenius Kabi USA, LLC Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.